Another way is to measure biomarkers such as IL-1β, IL-6, E-selectin, or VCAM-1-associated CRP (C reactive protein), which are increased in atherosclerotic lesions that can be seen using paraclinical examination such as Doppler echography for peripheral lesions or coronagraphy for coronary atherosclerosis. This evidence concerns the gene CRP and coronary atherosclerosis.